Back
Plus Therapeutics Stock Price Chart
Sponsored
PSTV
Sponsored
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
21
PSTV
Plus Therapeutics
Last Price:
1.57
Seasonality Move:
-9.88%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PSTV is experiencing slight selling pressure.
Plus Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.49 | Buy |
20-day SMA: | 1.44 | Buy |
50-day SMA: | 1.58 | Buy |
200-day SMA: | 1.84 | Sell |
8-day EMA: | 1.52 | Buy |
20-day EMA: | 1.48 | Buy |
50-day EMA: | 1.56 | Buy |
200-day EMA: | 1.95 | Sell |
Plus Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 57.37 | Buy |
Chaikin Money Flow: | -11608 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.35 - 1.55) | Buy |
Bollinger Bands (100): | (1.46 - 2.1) | Sell |
Plus Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Plus Therapeutics Stock
Is Plus Therapeutics Stock a Buy?
- Plus Therapeutics share price is 1.60 while PSTV 8-day simple moving average is 1.49, which is a Buy signal.
- The stock price of PSTV is 1.60 while Plus Therapeutics 20-day SMA is 1.44, which makes it a Buy.
- Plus Therapeutics 50-day simple moving average is 1.58 while PSTV share price is 1.60, making it a Buy technically.
- PSTV stock price is 1.60 and Plus Therapeutics 200-day simple moving average is 1.84, creating a Sell signal.
PSTV Technical Analysis vs Fundamental Analysis
Sell
21
Plus Therapeutics (PSTV)
is a Sell
Is Plus Therapeutics a Buy or a Sell?
-
Plus Therapeutics stock is rated a Sell
The current Plus Therapeutics [PSTV] share price is $1.60. The Score for PSTV is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
Plus Therapeutics Stock Info
Market Cap:
9.43M
Price in USD:
1.60
Share Volume:
69.65K
Plus Therapeutics 52-Week Range
52-Week High:
2.78
52-Week Low:
0.97
Sell
21
Plus Therapeutics (PSTV)
is a Sell
Plus Therapeutics Share Price Forecast
-
What is the Plus Therapeutics stock price today?
The Plus Therapeutics stock price is 1.60 USD today. -
Will PSTV stock go up or go down?
Plus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Plus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Plus Therapeutics is overvalued.
Is Plus Therapeutics Stock a Buy?
- Plus Therapeutics share price is 1.60 while PSTV 8-day exponential moving average is 1.52, which is a Buy signal.
- The stock price of PSTV is 1.60 while Plus Therapeutics 20-day EMA is 1.48, which makes it a Buy.
- Plus Therapeutics 50-day exponential moving average is 1.56 while PSTV share price is 1.60, making it a Buy technically.
- PSTV stock price is 1.60 and Plus Therapeutics 200-day simple moving average is 1.95, creating a Sell signal.
Fundamental Analysis of Plus Therapeutics
Is Plus Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.61 per share, an increase next quarter of $0.02 per share, an increase this year of $2.64 per share, and an increase next year of $0.17 per share.
Technical Analysis of Plus Therapeutics
Should I short Plus Therapeutics stock?
- PSTV Moving Average Covergence Divergence (MACD) indicator is 0, suggesting Plus Therapeutics is a Buy
- Plus Therapeutics Relative Strength Index (RSI) is 57.37, which suggest Plus Therapeutics is overbought
- The Bollinger Bands (25) for Plus Therapeutics is (1.35 - 1.55), which suggest Plus Therapeutics is a Sell
- The Bollinger Bands (100) for Plus Therapeutics is (1.46 - 2.1), which suggest Plus Therapeutics is a Sell
* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.